Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription


1 Am J Clin Pathol
8 BJU Int
1 BMC Urol
1 Br J Radiol
1 Cancer Imaging
4 Int J Urol
2 J Magn Reson Imaging
1 J Natl Cancer Inst
1 J Nucl Med
3 J Urol
1 Nat Rev Urol
1 PLoS One
4 Prostate
1 Radiology
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Clin Pathol

  1. SEMBA R, Uchida K, Hirokawa Y, Shiraishi T, et al
    A simple risk stratification model for prostate cancer using histopathologic findings of radical prostatectomy.
    Am J Clin Pathol. 2024 May 5:aqae049. doi: 10.1093.
    PubMed         Abstract available

    BJU Int

  2. LENFANT L, Beitone C, Troccaz J, Roupret M, et al
    Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three-dimensional transrectal ultrasonography segmentation.
    BJU Int. 2024;133:709-716.
    PubMed         Abstract available

  3. MAURER J, Friedemann T, Chen Y, Ambrosini F, et al
    A randomized controlled study on acupuncture for peri-operative pain after open radical prostatectomy.
    BJU Int. 2024;133:725-732.
    PubMed         Abstract available

  4. NOLSOE AB, Ostergren PB, Jakobsen H, Jensen CFS, et al
    Can nerve monitoring during radical prostatectomy improve functional outcomes? A randomised trial.
    BJU Int. 2024;133:742-751.
    PubMed         Abstract available

  5. FRANCO A, Ditonno F, Manfredi C, Licari LC, et al
    Robot-assisted single-port transvesical enucleation of the prostate: step-by-step technique and early single-centre experience.
    BJU Int. 2024;133:778-782.

  6. PASANEN N, Talala K, Remmers S, Tammela TLJ, et al
    Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer.
    BJU Int. 2024 May 9. doi: 10.1111/bju.16394.
    PubMed         Abstract available

  7. Prostate cancer: To screen, or not to screen? That is the question.
    BJU Int. 2024;133:635-637.

  8. ALMEIDA-MAGANA R, Au M, Al-Hammouri T, Dinneen K, et al
    Improving fluorescence confocal microscopy for margin assessment during robot-assisted radical prostatectomy: The LaserSAFE technique.
    BJU Int. 2024;133:677-679.

  9. MAC CURTAIN BM, Sugrue DD, Qian W, O'Callaghan M, et al
    Membranous urethral length and urinary incontinence following robot-assisted radical prostatectomy: a systematic review and meta-analysis.
    BJU Int. 2024;133:646-655.
    PubMed         Abstract available

    BMC Urol

  10. LOKESHWAR SD, Ali A, Weiss TR, Reynolds J, et al
    The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    BMC Urol. 2024;24:102.
    PubMed         Abstract available

    Br J Radiol

  11. MARTINI F, Pigati M, Mattiauda M, Ponzano M, et al
    Extra-prostatic extension (EPE) grading system: Correlation with MRI features and integration of capsular enhancement sign (CES) for "enhanced" detection of T3a lesions.
    Br J Radiol. 2024 Mar 27:tqae065. doi: 10.1093.
    PubMed         Abstract available

    Cancer Imaging

  12. AYATI N, McIntosh L, Buteau J, Alipour R, et al
    Comparison of quantitative whole body PET parameters on [(68)Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prosta
    Cancer Imaging. 2024;24:57.
    PubMed         Abstract available

    Int J Urol

  13. ANDO S, Sugihara T, Hinotsu S, Kishino H, et al
    Early recovery of urinary continence after robot-assisted radical prostatectomy is associated with membranous urethra and neurovascular bundle preservation.
    Int J Urol. 2024;31:492-499.
    PubMed         Abstract available

  14. CHIARELLI G, Davis M, Stephens A, Cirulli GO, et al
    Comparison of patient background between a real-world North American cohort and the Goteborg-2 trial.
    Int J Urol. 2024;31:562-567.
    PubMed         Abstract available

  15. SAMIRAE L, Krausewitz P, Alajati A, Kristiansen G, et al
    The relevance of circRNAs in serum of patients undergoing prostate biopsy.
    Int J Urol. 2024;31:578-580.

  16. URABE F
    The relevance of circRNAs in serum of patients undergoing prostate biopsy.
    Int J Urol. 2024;31:581.

    J Magn Reson Imaging

  17. WOERNLE A, Englman C, Dickinson L, Kirkham A, et al
    Picture Perfect: The Status of Image Quality in Prostate MRI.
    J Magn Reson Imaging. 2023 Oct 7. doi: 10.1002/jmri.29025.
    PubMed         Abstract available

  18. MOSES DA, Ho Shon I
    Editorial for "Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management".
    J Magn Reson Imaging. 2024 May 7. doi: 10.1002/jmri.29426.

    J Natl Cancer Inst

  19. BJORNEBO L, Razdan S, Discacciati A, Palsdottir T, et al
    Prostate Cancer Incidence and Mortality in Men Exposed to alpha1-Adrenoceptor Antagonists.
    J Natl Cancer Inst. 2024 May 8:djae108. doi: 10.1093.
    PubMed         Abstract available

    J Nucl Med

  20. ZANG J, Yang Y, Chen S, Wang C, et al
    Diagnostic Performance of [(18)F]AlF-Thretide PET/CT in Patients with Newly Diagnosed Prostate Cancer Using Histopathology as Reference Standard.
    J Nucl Med. 2024 May 9:jnumed.123.266940. doi: 10.2967/jnumed.123.266940.
    PubMed         Abstract available

    J Urol

  21. TRINH QD, Labban M, Daniels D, Feldman A, et al
    Empowering Communities: Fostering Prostate Cancer Awareness and Resilience Among Men of Color.
    J Urol. 2024 May 4:101097JU0000000000003931. doi: 10.1097/JU.0000000000003931.

  22. MOSES RA, Hunter AE, Brandes ER, Zhang Z, et al
    Patient-Reported Outcome Measures Following Hyperbaric Oxygen Therapy for Radiation Cystitis: Early Results From the Multicenter Registry for Hyperbaric Oxygen Therapy.
    J Urol. 2024;211:765-774.
    PubMed         Abstract available

  23. MIAN BM
    Reply: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial.
    J Urol. 2024;211:802-803.

    Nat Rev Urol

    Patient-reported toxic effects of hypofractionated versus conventional RT.
    Nat Rev Urol. 2024;21:257.

    PLoS One

  25. KADRY MO, Abdel-Megeed RM
    CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
    PLoS One. 2024;19:e0302264.
    PubMed         Abstract available


  26. CHECCUCCI E, De Cillis S, Alladio E, Piramide F, et al
    Ten-year functional and oncological outcomes of a prospective randomized controlled trial comparing laparoscopic versus robot-assisted radical prostatectomy.
    Prostate. 2024;84:832-841.
    PubMed         Abstract available

  27. HEETMAN JG, Paulino Pereira LJ, Kelder JC, Soeterik TFW, et al
    The additional value of (68)Ga-PSMA PET/CT SUVmax in predicting ISUP GG >/= 2 and ISUP GG >/= 3 prostate cancer in biopsy.
    Prostate. 2024 May 5. doi: 10.1002/pros.24716.
    PubMed         Abstract available

  28. YIN J, Daryanani A, Lu F, Ku AT, et al
    Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis.
    Prostate. 2024 May 6. doi: 10.1002/pros.24718.
    PubMed         Abstract available

  29. ASHIDA S, Kawada C, Tanaka H, Kurabayashi A, et al
    Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer.
    Prostate. 2024 May 9. doi: 10.1002/pros.24723.
    PubMed         Abstract available


  30. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
    Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
    Radiology. 2024;311:e230750.
    PubMed         Abstract available


  31. MILLOT J, Arenas-Gallo C, Silver E, Goldman M, et al
    Reply by Authors - Major Complications and Adverse Events Related to use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy.
    Urology. 2024 May 6:S0090-4295(24)00345-5. doi: 10.1016/j.urology.2024.

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.